Product Information
MEXILETINE 250 MG CAPSULE is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.4464 per EA under NDC 62559082201. Its NADAC has been published 256 times since Sep 2, 2020.
Strength
250 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559082201
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
MEXILETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074450On Market Since
6/22/2020
Pharmacological Classes
Price Statistics
The NADAC for MEXILETINE 250 MG CAPSULE has been published 256 times since Sep 2, 2020, and over the history we have for it it has declined 67.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4464 per EA |
|---|---|
| All-time high | $1.5088 (Jan 13, 2021) |
| All-time low | $0.4101 (Nov 19, 2025) |
| 52-week high | $0.4943 |
| 52-week low | $0.4101 |
| Median price | $1.0421 |
| Average price | $0.9057 |
| Largest weekly change | -57.2% (Apr 17, 2024) |
| Weeks tracked | 256 |
| Tracking since | Sep 2, 2020 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of MEXILETINE 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MEXILETINE 250 MG CAPSULE, manufactured by ANI Pharmaceuticals, Inc., is $0.4464 per EA (NDC 62559082201), effective Jun 24, 2026.
How has the price of MEXILETINE 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MEXILETINE 250 MG CAPSULE has declined 67.8%. It has been tracked across 256 weekly CMS publications since Sep 2, 2020.
What are the highest and lowest recorded NADAC prices for MEXILETINE 250 MG CAPSULE?
Since Sep 2, 2020, the NADAC for MEXILETINE 250 MG CAPSULE has ranged from a low of $0.4101 (Nov 19, 2025) to a high of $1.5088 (Jan 13, 2021), with a median of $1.0421 per EA.
Are there cheaper alternatives to MEXILETINE 250 MG CAPSULE?
3 NADAC-published products share the same active ingredient, strength, and dosage form as MEXILETINE 250 MG CAPSULE, but none are currently priced below it.
Who manufactures MEXILETINE 250 MG CAPSULE?
MEXILETINE 250 MG CAPSULE (NDC 62559082201) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification